ArticleOncology letters2015

Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

Hiroshi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.